Votrient 200 mg Tablet
$98.42
$92.92
Votrient 200 mg tablets are a potent treatment option classified as tyrosine kinase inhibitors, specifically designed for managing advanced kidney cancer and soft tissue sarcoma (STS), which affects the body’s supportive tissues like muscles and fat. By blocking certain proteins that promote cancer cell growth, Votrient effectively slows disease progression and may improve patient outcomes. It is essential to note that the safety and effectiveness of Votrient in pediatric patients aged 2 to 18 years have not been established, necessitating caution in this age group. Common side effects can include fatigue, nausea, and diarrhea, among others, which should be monitored closely. Patients are advised to discuss any pre-existing conditions and medications with their healthcare provider to avoid potential interactions. Overall, Votrient represents a crucial option for individuals battling these challenging cancers, underscoring the importance of personalized treatment plans. Always consult a healthcare professional for tailored advice and support during your treatment journey.
मात्रा
Active Pharmaceutical Ingredient
Uses
• Votrient 200 mg tablet is primarily used to treat advanced renal cell carcinoma, a type of kidney cancer. It works by inhibiting specific pathways that cancer cells use to grow and spread. Patients taking Votrient 200 mg tablet may experience a reduction in tumor size, which can be beneficial in managing their condition. This treatment is often part of a comprehensive cancer management plan.
• In addition to kidney cancer, Votrient 200 mg tablet is also effective for treating soft tissue sarcoma in patients who have previously received chemotherapy. This medication helps slow the progression of the disease and can improve overall survival rates. Patients are typically prescribed Votrient 200 mg tablet when other treatment options have been exhausted. It plays a crucial role in extending the duration of response in difficult-to-treat cases.
• Votrient 200 mg tablet can be beneficial for patients with gastrointestinal stromal tumors (GIST) that are unresectable or metastatic. By targeting the specific mutations associated with GIST, this medication helps manage the disease more effectively. Patients taking Votrient 200 mg tablet may find that their symptoms improve as the tumor's activity is controlled. This targeted approach is essential for enhancing the quality of life in affected individuals.
• The use of Votrient 200 mg tablet is also significant in clinical settings for patients who require long-term management of their cancer. Regular administration can lead to sustained disease control, making it a vital part of ongoing treatment strategies. Healthcare providers often monitor patients closely while they are on Votrient 200 mg tablet to ensure optimal therapeutic outcomes. This consistent management helps support better overall health during cancer treatment.
Benefits
Kidney cancer, also known as renal cancer, is a type of cancer that begins in the kidneys, which are vital organs responsible for filtering waste products and excess fluids from the blood, producing urine, and maintaining the overall functions of the body. Pazopanib 200 mg Tablet can stop cancer from growing and prevent cancer cells from multiplying. This helps to stop cancer from spreading to other unaffected areas. You will need to follow your doctor's instructions very carefully to help you recover.
Soft tissue sarcoma: This is a rare form of cancer that starts in the soft parts of the body. These include muscle, sinew, fat, vascular, and nervous tissue. Anti-cancer Drug Votrient works by killing or stopping the growth of cancer cells and by preventing the cancer cells from multiplying. If any of the side effects bother you, tell your doctor or health care professional.
Side Effects
Like all medicines, Anti-cancer Drug Votrient may cause side effects that do not require medical attention and that will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.
Most Common Side Effects
• Stomach pain
• Loss of appetite
• Nausea
• Vomiting
• Diarrhea
• Weight loss
• Headache
• Loss of taste
• Sore mouth
• Lack of energy
• Changes in hair colour
• Unusual hair loss
• Skin rash
• Headache
• Shortage of breath
• Bone, muscle and joint pain
Common Side Effects
• Swelling of the brain
• Sudden and severe rise in BP
• Increased risk of heart diseases
• Bleeding in the digestive system
• Liver problems
• Blood clots
• Tumor pain
• Blurry vision
• Lung disorders
How To Use
Votrient 200 mg Tablet can be taken orally once a day, preferably without food (at least 1 hour before or 2 hours after a meal). It is recommended that you swallow the tablet whole with a full glass of water and that you do not crush, chew or break the tablet. If you miss a dose of this medicine, take it as soon as you can. Skip the missed dose and return to your regular dosing schedule if it is almost time for your next dose. Do not take a double dose of your medicine to make up for a missed dose.
Safety Advice
• Alcohol: Drinking alcohol while taking Pazopanib 200 mg Tablet is generally not recommended. It may increase the risk of liver damage, and it is best to avoid alcohol or to limit the amount of alcohol you drink while you are taking this medicine.
• Kidney: For patients with kidney impairment, dose adjustment is not recommended. Votrient Cancer Medicine has not been studied in patients with severe renal impairment or in patients who are undergoing peritoneal dialysis or haemodialysis.
• Breastfeeding: There are no data on the presence of Votrient 200 mg or its metabolites in human milk or effects on nursing infants or lactation. Because of the potential for serious adverse reactions in nursing infants, women should be advised not to breastfeed during treatment with Votrient Cancer Medicine and for 2 weeks after the last dose.
• Liver: For patients with mild liver disease, Anti-cancer Drug Votrient is recommended. No dose adjustment is required in patients with mild liver impairment. However, Votrient 200 mg is not recommended for use in patients with moderate or severe liver disease.
• Pregnancy: The use of Votrient 200 mg Tablet is not recommended in pregnant women as it may cause harm to the foetus if administered to a pregnant woman.
• Driving: Pazopanib 200 mg Tablet does not alter or impair the ability to drive or use machines.